The Global Flow Diversion Aneurysm Treatment Market is forecasted to grow by USD 2,107.08 mn during 2022-2027, accelerating at a CAGR of 8.8% during the forecast period
Global Flow Diversion Aneurysm Treatment Market 2023-2027. The flow diversion aneurysm treatment market is forecasted to grow by USD 2,107.08 mn during 2022-2027, accelerating at a CAGR of 8.8% during the forecast period.
New York, Sept. 04, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Flow Diversion Aneurysm Treatment Market 2023-2027" - https://www.reportlinker.com/p05483050/?utm_source=GNW
The report on the flow diversion aneurysm treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing incidence of intracranial aneurysms, advancements in flow diverter technology, and minimally invasive treatment.
*The flow diversion aneurysm treatment market is segmented as below:*
By Product
• FDS
• Intrasaccular flow disruption devices
By End-user
• Hospitals
• Specialty clinics
By Geography
• North America
• Europe
• Asia
• Rest of World (ROW)
This study identifies the growing awareness and education as one of the prime reasons driving the flow diversion aneurysm treatment market growth during the next few years. Also, expanding indications of flow diversion procedures and advancements in endovascular technologies will lead to sizable demand in the market.
The report on the flow diversion aneurysm treatment market covers the following areas:
• Flow diversion aneurysm treatment market sizing
• Flow diversion aneurysm treatment market forecast
• Flow diversion aneurysm treatment market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading flow diversion aneurysm treatment market vendors that include Acandis GmbH, BALT Group, Cardinal Health Inc., Endologix LLC, Evasc Medical Systems Corp., Imperative Care Inc., InspireMD Inc., Johnson and Johnson, Lepu Medical Technology Beijing Co. Ltd., Medtronic Plc, Merlin MD Pte. Ltd., MicroPort Scientific Corp., Oxford Endovascular Ltd., Penumbra Inc., Rapid Medical Ltd., Siemens AG, Stryker Corp., Terumo Corp., Wallby Medical LLC, and InNeuroCo. Also, the flow diversion aneurysm treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Read the full report: https://www.reportlinker.com/p05483050/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
CONTACT: Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001